Golidocitinib is an oral inhibitor of the JAK/STAT signaling pathway, primarily indicated for the treatment of hematologic malignancies such as relapsed or refractory peripheral T-cell lymphoma (PTCL).
What is Golidocitinib?
Update: 06 Feb,2026 Source: Haiou Health Views: 108
